Abstract:<p>Placental dysfunction is a common obstetric problem that complicates 5 ‐ 10% of all pregnancies (1). It is a progressive condition, in which the fetal supply of oxygen and nutrients is insufficient to maintain normal fetal growth and organ development. The association between low birth weight and adverse neonatal outcome is well described (2). Moreover, there is evidence to support the hypothesis that common adult diseases such as metabolic syndrome and cardiovascular disease originate from abnormal fetal programming due to placental dysfunction ‐ also known as Barker's Hypothesis (3). Currently, there is no available treatment to improve placental function. However, correct antenatal identification of placental dysfunction leads to a four‐fold improvement in the neonatal outcome, as it allows for timely delivery and thereby reduces the risk of irreversible fetal organ damage (4). Current antenatal screening of placental dysfunction focuses on fetal weight estimates and fetal and umbilical Doppler flow measurements. However, fetal size does not exactly reflect placental function. In addition, in late onset placental dysfunction, Doppler flows usually remain normal (5).Therefore, additional markers that directly reflect placental function have the potential to considerably improve the antenatal screening of placental dysfunction. There is increasing interest in placental MRI, due to its potential to detect placental dysfunction in vivo. In particular, T2* weighted MRI has proven to be a simple and useful method to assess placental health, either studying the quantitative T2* relaxation time or the relative change in the raw T2* weighted signal in response to a given challenge (the BOLD response). T2* depends primarily on oxygenation but also on other tissue factors, including villous density, inhomogeneities in the distribution of oxygenated blood, magnetic field inhomogeneities, and the presence of other paramagnetic molecules (6). This paper aims to explain the physiological basis for changes in T2* weighted signal intensity in the placenta. Previous literature on T2* weighted placental MR is reviewed and reference values are provided for 1.5 and 3 T. Practical guidance on how to optimize the T2* weighted scans is included, and the clinical potential of T2* weighted imaging as an antenatal test of placental dysfunction is outlined.</p><p>This article is protected by copyright. All rights reserved.</p>

Two-dimensional (2D) placental ultrasound measurements – The correlation with placental volume measured by magnetic resonance imaging (MRI)

A retrospective segmentation analysis of placental volume by magnetic resonance imaging from first trimester to term gestation

In vivo placental MRI shape and textural features predict fetal growth restriction and postnatal outcome

Value of 3D Ultrasonographic Assessment of Placental Volume and Perfusion Indices in The First Trimester As Predictors to The Occurrence of Preeclampsia

Diagnostic accuracy of magnetic resonance imaging to predict peripartum hysterectomy and neonatal mortality in total placenta previa: A retrospective cohort study

Three-dimensional power Doppler ultrasound evaluation of placental blood flow in normal monochorionic diamniotic twin pregnancies

The Use of Three-Dimensional Power Doppler Ultrasound in Assessment of Placental Blood Flow and Volume and Its Correlation with Severity of Preeclampsia

T2*‐weighted placental MRI: basic research tool or emerging clinical test for placental dysfunction?

Reference Ranges of 2-Dimensional Placental Biometry and 3-Dimensional Placental Volume between 11 and 14 Weeks of Gestation

Are placental MRI examinations prior to 24 weeks’ gestation reliable in detecting abnormal placentation compared with ultrasound?

An assessment of vascularity and flow intensity of the placenta in normal pregnancy and pre-eclampsia using three-dimensional ultrasound

Serial evaluation of morphological and biophysical placental attributes in women with normal outcome and preeclampsia

Detecting Accuracy of Three Dimensional Power Doppler (3DPD) Vascular Indices for Prenatal Diagnosis of Morbidly Adherent Placenta in Patients with Placenta Previa

Alteration of vascularization in preeclamptic placentas measured by three-dimensional power Doppler ultrasound

EP01.13: A new method for placental volume measurements using tracked two‐dimensional ultrasound and automatic image segmentation

Investigation Into the Predictive Potential of Three-Dimensional Ultrasonographic Placental Volume and Vascular Indices in Gestational Diabetes Mellitus

Comparison of 2D and 3D oxygen-enhanced MRI of the placenta

Application Value of Two‐Dimensional Ultrasound Combined With Three‐Dimensional Power Doppler in the Prediction of Macrosomia in Early Pregnancy

Magnetic resonance imaging diagnosis of abnormal placental cord insertions

Ultrasound And Mri Accordance And Features In The Prenatal Diagnosis Of Placenta Accreta

Single vs. multi-slice assessments of in vivo placental T2∗ measurements